[1]
V. NV, N. EK, J. Jones, G. Muttath, S. Nayanar, and F. NP, “An Audit of Efficacy and Toxicity of Neoadjuvant Paclitaxel and Trastuzumab in HER- 2 Postive Locally Advanced Breast Cancer”, apjcc, vol. 10, no. 2, pp. 387-391, Apr. 2025.